Inherited alleles can alter physiological or behavioral traits, while spontaneous mutations introduce additional genetic differences within a strain lineage. Breeding history then preserves or redistributes these variants across strains and substrains. As a result, mice used in otherwise similar experiments may show different disease susceptibility or treatment responses, making genetic background an important experimental variable.
Genotype interacts with conditions such as housing, diet, and microbiota, so environmental differences can modify how inherited traits appear. These interactions may influence physiology, behavior, disease-related phenotypes, or responses to treatment. Consequently, a finding observed in one environmental setting may not transfer directly to another unless those conditions are considered during interpretation.
Substrains may differ because of separate breeding histories and accumulated spontaneous mutations, even when they share a broader strain designation. Those differences can affect experimentally relevant phenotypes and introduce variation between facilities or studies. Identifying the specific substrain therefore helps researchers interpret conflicting results and avoid treating genetically distinct mouse populations as interchangeable.
Selection should reflect the study question and the traits most relevant to it, including physiology, behavior, disease susceptibility, and treatment response. Researchers can also compare more than one strain when genetic influences are central to the investigation. Recording the strain or substrain and relevant environmental conditions improves interpretation and supports reproducibility.
At minimum, researchers should record the genetic background or specific substrain together with environmental factors known to interact with genotype. Housing conditions, diet, and microbiota are particularly relevant because they can modify observed phenotypes. Documenting these variables helps distinguish effects associated with genetic differences from effects associated with differences in experimental context.
Comparing strains can reveal genetic factors associated with disease mechanisms, susceptibility, or therapeutic outcomes. In drug testing, immunology, and other preclinical studies, these comparisons may show whether a response depends on genetic background rather than representing a general effect. Such evidence can improve experimental design, clarify treatment interpretation, and strengthen reproducibility across studies.